These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16436310)

  • 21. Multimethod research into policy changes in the pharmacy sector--the Nordic case.
    Almarsdóttir AB; Traulsen JM
    Res Social Adm Pharm; 2009 Mar; 5(1):82-90. PubMed ID: 19285293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health, health care, and incompletely theorized agreements: a normative theory of health policy decision making.
    Ruger JP
    J Health Polit Policy Law; 2007 Feb; 32(1):51-87. PubMed ID: 17312325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring mechanisms that explain how coalition groups are formed and how they work to sustain political priority for maternal and child health in Nigeria using the advocacy coalition framework.
    Okeke C; Manzano A; Obi U; Etiaba E; Onwujekwe O; Mirzoev T; Uzochukwu B
    Health Res Policy Syst; 2021 Mar; 19(1):26. PubMed ID: 33648536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Foundation's consumer advocacy health reform initiative strengthened groups' effectiveness.
    Strong D; Lipson D; Honeycutt T; Kim J
    Health Aff (Millwood); 2011 Sep; 30(9):1799-803. PubMed ID: 21900672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pill testing policy: A comparative analysis using the Advocacy Coalition Framework.
    Sommerville K; Ritter A; Stephenson N
    Drug Alcohol Rev; 2022 Jan; 41(1):275-284. PubMed ID: 34252242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk avoidance and missed opportunities in mental health reform: the case of Israel.
    Aviram U; Guy D; Sykes I
    Int J Law Psychiatry; 2007; 30(3):163-81. PubMed ID: 17467055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Menu-labeling policy in King County, Washington.
    Johnson DB; Payne EC; McNeese MA; Allen D
    Am J Prev Med; 2012 Sep; 43(3 Suppl 2):S130-5. PubMed ID: 22898162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The medicine user--lost in translation? Analysis of the official political debate prior to the deregulation of the Danish medicine distribution system.
    Noerreslet M; Larsen JB; Traulsen JM
    Soc Sci Med; 2005 Oct; 61(8):1733-40. PubMed ID: 15923071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perspectives on Drug and Therapeutics Committee policy implementation.
    Tan EL; Day RO; Brien JA
    Res Social Adm Pharm; 2005 Dec; 1(4):526-45. PubMed ID: 17138494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brokering health policy: coalitions, parties, and interest group influence.
    Heaney MT
    J Health Polit Policy Law; 2006 Oct; 31(5):887-944. PubMed ID: 17102139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peer, professional, and public: an analysis of the drugs policy advocacy community in Europe.
    O'Gorman A; Quigley E; Zobel F; Moore K
    Int J Drug Policy; 2014 Sep; 25(5):1001-8. PubMed ID: 24974366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fighting a tobacco-tax rollback: a political analysis of the 1994 cigarette contraband crisis in Canada.
    Breton E; Richard L; Gagnon F; Jacques M; Bergeron P
    J Public Health Policy; 2006; 27(1):77-99. PubMed ID: 16681189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health care policy in theory and practice: a review of the process as a product of rational decision-making.
    Prosono M
    J Health Soc Policy; 1998; 9(4):83-99. PubMed ID: 10180602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A framework for assessing the effectiveness of antihunger advocacy organizations.
    Laraia BA; Dodds J; Eng E
    Health Educ Behav; 2003 Dec; 30(6):756-70. PubMed ID: 14655868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using the Advocacy Coalition Framework to understand EU pharmaceutical policy.
    Brooks E
    Eur J Public Health; 2018 Nov; 28(suppl_3):11-14. PubMed ID: 30383259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementing competition in the pharmacy sector: lessons from Iceland and Norway.
    Anell A; Hjelmgren J
    Appl Health Econ Health Policy; 2002; 1(3):149-56. PubMed ID: 14619266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The road less traveled: nursing advocacy at the policy level.
    Spenceley SM; Reutter L; Allen MN
    Policy Polit Nurs Pract; 2006 Aug; 7(3):180-94. PubMed ID: 17071705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence-based policy or policy-based evidence? The role of evidence in the development and implementation of the Illicit Drug Diversion Initiative.
    Hughes CE
    Drug Alcohol Rev; 2007 Jul; 26(4):363-8. PubMed ID: 17564871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Gateway Paper--context and configuration of the proposed health reforms in Pakistan.
    Nishtar S
    J Pak Med Assoc; 2006 Dec; 56(12 Suppl 4):S2-13. PubMed ID: 17595829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using the Advocacy Coalition Framework and Multiple Streams policy theories to examine the role of evidence, research and other types of knowledge in drug policy.
    Ritter A; Hughes CE; Lancaster K; Hoppe R
    Addiction; 2018 Aug; 113(8):1539-1547. PubMed ID: 29664153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.